Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-27 @ 11:25 PM
Study NCT ID:
NCT06791460
Status:
RECRUITING
Last Update Posted:
2025-03-18
First Post:
2025-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer
Sponsor:
Obstetrics & Gynecology Hospital of Fudan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-03-18
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-02-14
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-02-14
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-17
First Submit QC Date:
None
Study First Post Date:
2025-01-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-17
Last Update Post Date:
2025-03-18
Last Update Post Date Type:
ACTUAL